Jeffrey A Hussmann

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Top Venues

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Luke W Koblan, Mandana Arbab, Max W Shen, Jeffrey A Hussmann, Andrew V Anzalone, Jordan L Doman, Gregory A Newby, Dian Yang, Beverly Mok, Joseph M Replogle, Albert Xu, Tyler A Sisley, Jonathan S Weissman, Britt Adamson, David R Liu
Author Correction: Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nature biotechnology (2023)
Luke W Koblan, Mandana Arbab, Max W Shen, Jeffrey A Hussmann, Andrew V Anzalone, Jordan L Doman, Gregory A Newby, Dian Yang, Beverly Mok, Joseph M Replogle, Albert Xu, Tyler A Sisley, Jonathan S Weissman, Britt Adamson, David R Liu
Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nature biotechnology 39 (11) (2021)
Joseph M Replogle, Thomas M Norman, Albert Xu, Jeffrey A Hussmann, Jin Chen, J Zachery Cogan, Elliott J Meer, Jessica M Terry, Daniel P Riordan, Niranjan Srinivas, Ian T Fiddes, Joseph G Arthur, Luigi J Alvarado, Katherine A Pfeiffer, Tarjei S Mikkelsen, Jonathan S Weissman, Britt Adamson
Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing. Nature biotechnology 38 (8) (2020)
Marco Jost, Daniel A Santos, Reuben A Saunders, Max A Horlbeck, John S Hawkins, Sonia M Scaria, Thomas M Norman, Jeffrey A Hussmann, Christina R Liem, Carol A Gross, Jonathan S Weissman
Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs. Nature biotechnology 38 (3) (2020)